Cambridge Cognition Holdings PLC Block Listing Return

RNS Number : 7452H

Cambridge Cognition Holdings PLC

10 October 2024

Cambridge Cognition Holdings plc

("Cambridge Cognition", the "Company" or the "Group")

Block Listing Return

The Company makes the following notification pursuant to AIM Rule 29 and Schedule Six of the AIM Rules for Companies, regarding its existing block listings:

Name of applicant:		Cambridge Cognition Holdings plc
Name of scheme:		Share Options
Period of return:	From:	1 April 2024	To:	1 October 2024
Number and class of share(s) (amount of stock / debt securities) originally listed and the date of admission:		1,000,000 ordinary shares of £0.01 each in the Company admitted to trading on 23 March 2023
Balance of unallotted securities under scheme(s) from previous return:		466,316 ordinary shares
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):		Nil
Less: Number of securities issued/allotted under scheme(s) during period:		Nil
Equals: Balance under scheme(s) not yet issued/allotted at end of period:		466,316 ordinary shares

Name of contact:	Simon McKeating
Telephone number of contact:	+44 (0)1223 810700

Enquiries:

Cambridge Cognition Holdings plc

Dr Steven Powell, Chairman

c/o Hudson Sandler

Hudson Sandler (Financial PR and IR)

Dan de Belder / Hattie Dreyfus

Tel: 020 7796 4133

cog@hudsonsandler.com

Panmure Liberum Limited (NOMAD and Joint Broker)

Will Goode / Freddy Crossley / Mark Rogers

Rupert Dearden

Tel: 020 7886 2968

(Corporate Finance)

(Corporate Broking)

Dowgate Capital Limited (Joint Broker)

David Poutney / Nick Chambers

Tel: 020 3903 7715

Notes to Editors

About Cambridge Cognition

Cambridge Cognition is a technology company developing digital health products to better understand, detect and treat conditions affecting brain health. The Company's software products assess cognitive health in patients worldwide to improve clinical trial outcomes, identify and stratify patients early and improve global efficiency in pharmaceutical and healthcare industries.

For further information visit: https://cambridgecognition.com/

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

BLREAFEEFLDLFFA

Cambridge Cognition (LSE:COG)
과거 데이터 주식 차트
부터 10월(10) 2024 으로 11월(11) 2024